111 Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
111 Capital's BMY Position: Q2 2026 in Review
111 Capital opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,419 shares worth $312K. The stake represents 0.05% of the portfolio and ranks #345 among its holdings. This is a return to the name: 111 Capital previously reported a position in BMY as recently as Q4 2025.
111 Capital first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $992K in Q4 2024. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- 111 Capital held 5,419 shares of Bristol-Myers Squibb worth $312K as of Q2 2026.
- Bristol-Myers Squibb was a new 111 Capital position in Q2 2026.
- Bristol-Myers Squibb made up 0.05% of 111 Capital's portfolio in Q2 2026, its #345 holding.
- 111 Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
- 111 Capital's Bristol-Myers Squibb position peaked at $992K in Q4 2024.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.